Situs Corp.
This article was originally published in Start Up
Executive Summary
Only a third or less of the population that suffers from urge incontinence seeks treatment, and half of the patients that do discontinue treatment because of the unpleasant side effects of orally-administered drugs that are currently on the market. Situs Corp. hopes to improve upon the efficacy of these drugs and avoid side effects by delivering drug directly into the bladder. The company is developing both formulations of drugs for intravesical (in the bladder) delivery as well as a delivery device.